SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-013685
Filing Date
2024-04-29
Accepted
2024-04-29 16:11:10
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A ctdh20231231_10ka.htm   iXBRL 10-K/A 55170
2 EXHIBIT 31.1 ex_661080.htm EX-31.1 12717
3 EXHIBIT 31.2 ex_661075.htm EX-31.2 12711
  Complete submission text file 0001437749-24-013685.txt   310697

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231231.xsd EX-101.SCH 3891
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231231_def.xml EX-101.DEF 19424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231231_lab.xml EX-101.LAB 26085
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231231_pre.xml EX-101.PRE 20281
19 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231231_10ka_htm.xml XML 8427
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39780 | Film No.: 24890837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)